Search

Abstract: The initial results from clinical trials investigating the utility of acoustic radiation force impulse (ARFI) imaging for use with radio-frequency ablation (RFA) procedures in the liver are presented. To date, data have been collected from 6 RFA procedures in 5 unique patients. Large displacement contrast was observed in ARFI images of both pre-ablation malignancies (mean 7.5 dB, range 5.7–11.9 dB) and post-ablation thermal lesions (mean 6.2 dB, range 5.1–7.5 dB). In general, ARFI images provided superior boundary definition of structures relative to the use of conventional sonography alone. Although further investigations are required, initial results are encouraging and demonstrate the clinical promise of the ARFI method for use in many stages of RFA procedures. (E-mail: bfahey04@gmail.com) [Copyright &y& Elsevier]

Abstract: The effect of physiological motion on the quality of radiation force elasticity images has been investigated. Experimental studies and simulated images were used to investigate the impact of motion effects on image quality metrics over a range of clinically realistic velocity and acceleration magnitudes. Evaluation criteria included motion filter effectiveness, image signal-to-noise ratio (SNR) and the contrast-to-noise ratio (CNR) of a stiff inclusion embedded in a homogeneous background material. Two transmit frequencies (2.5 and 4.4 MHz) were analyzed and contrasted in terms of image quality over a range of target motions. Results indicate that situations may exist where liver and cardiac motion magnitudes lead to poor image quality, but optimized transducer orientations may help suppress motion artifacts if some a priori information concerning target motion characteristics is known. In the presence of significant target motion, utilizing a lower transmit frequency can improve SNR and CNR in elasticity images. (E-mail: brian.fahey@duke.edu). [Copyright &y& Elsevier]

Abstract: The feasibility of utilizing acoustic radiation force impulse (ARFI) imaging to assess the mechanical properties of abdominal tissues was investigated. The thermal safety of the technique was also evaluated through the use of finite element method models. ARFI imaging was shown to be capable of imaging abdominal tissues at clinically realistic depths. Correspondence between anatomical structures in B-mode and ARFI images was observed. ARFI images showed similar tumor contrast when compared with B-mode images of ex vivo abdominal cancers. Finite element method models and in vitro measurements confirmed the thermal safety of ARFI imaging at depth. ARFI imaging is inexpensive, safe and convenient and is a promising modality for use in abdominal imaging. (E-mail: brian.fahey@duke.edu) [Copyright &y& Elsevier]

The ability of acoustic radiation force impulse (ARFI) imaging to visualize thermally- and chemically-induced lesions in soft tissues was investigated. Lesions were induced in freshly excised bovine liver samples. Chemical lesions were induced via the injection of formaldehyde and thermal lesions were created using a radiofrequency (RF) ablation system. Although conventional sonography was unable to visualize induced lesions, ARFI imaging was capable of monitoring lesion size and boundaries. Agreement was observed between lesion size in ARFI images and in results from pathology. The fact that ARFI imaging requires no additional equipment aside from that needed for conventional ultrasonic imaging makes it a promising modality for monitoring lesion development in situations where sonography is already involved as a guiding mechanism, such as in procedures requiring precise catheter placement. (brian.fahey@duke.edu) [Copyright &y& Elsevier]

Introduction The combination of the LUCAS 2 (L-CPR) automated CPR device and an impedance threshold device (ITD) has been widely implemented in the clinical field. This animal study tested the hypothesis that the addition of an ITD on L-CPR would enhance cerebral and coronary perfusion pressures. Methods Ten female pigs (39.0 ± 2.0 kg) were sedated, intubated, anesthetized with isofluorane, and paralyzed with succinylcholine (93.3 μg/kg/min) to inhibit the potential confounding effect of gasping. After 4 min of untreated ventricular fibrillation, 4 min of L-CPR + an active ITD or L-CPR + a sham ITD was initiated and followed by another 4 min of the alternative method of CPR. Systolic blood pressure (SBP), diastolic blood pressure (DBP), diastolic right atrial pressure (RAP), intracranial pressure (ICP), airway pressure, and end tidal CO 2 (ETCO 2 ) were recorded continuously. Data expressed as mean mmHg ± SD. Results Decompression phase airway pressure was significantly lower with L-CPR + active ITD versus L-CPR + sham ITD (−5.3 ± 2.2 vs. −0.5 ± 0.6; p < 0.001). L-CPR + active ITD treatment resulted in significantly improved hemodynamics versus L-CPR + sham ITD: ETCO 2 , 35 ± 6 vs. 29 ± 7 ( p = 0.015); SBP, 99 ± 9 vs. 93 ± 15 ( p = 0.050); DBP, 24 ± 12 vs. 19 ± 15 ( p = 0.006); coronary perfusion pressure, 29 ± 8 vs. 26 ± 7 ( p = 0.004) and cerebral perfusion pressure, 24 ± 13 vs. 21 ± 12 ( p = 0.028). Conclusions In pigs undergoing L-CPR the addition of the active ITD significantly reduced intrathoracic pressure and increased vital organ perfusion pressures. [ABSTRACT FROM AUTHOR]

Abstract: Electrophysiological and pharmacological studies coupled with molecular identification have revealed a unique network of ion channels—Kv1.3, KCa3.1, CRAC (Orai1 + Stim1), TRPM7, Clswell—in lymphocytes that initiates and maintains the calcium signaling cascade required for activation. The expression pattern of these channels changes during lymphocyte activation and differentiation, allowing the functional network to adapt during an immune response. The Kv1.3 channel is of interest because it plays a critical role in subsets of T and B lymphocytes implicated in autoimmune disorders. The ShK toxin from the sea anemone Stichodactyla helianthus is a potent blocker of Kv1.3. ShK-186, a synthetic analog of ShK, is being developed as a therapeutic for autoimmune diseases, and is scheduled to begin first-in-man phase-1 trials in 2011. This review describes the journey that has led to the development of ShK-186. [Copyright &y& Elsevier]